Page last updated: 2024-09-05

sb 203580 and Rhabdomyosarcoma, Alveolar

sb 203580 has been researched along with Rhabdomyosarcoma, Alveolar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hosoi, H; Houghton, PJ; Misawa-Furihata, A; Sugimoto, T; Tsuchiya, K	1

Other Studies

1 other study(ies) available for sb 203580 and Rhabdomyosarcoma, Alveolar

Article	Year
Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells. International journal of oncology, 2007, Volume: 31, Issue:1 Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Cycle; Cell Line, Tumor; Humans; Imidazoles; Insulin-Like Growth Factor I; Muscle Development; Myogenin; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Receptor, IGF Type 1; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sirolimus; TOR Serine-Threonine Kinases	2007

Article

Year

Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.

International journal of oncology, 2007, Volume: 31, Issue:1

Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Cycle; Cell Line, Tumor; Humans; Imidazoles; Insulin-Like Growth Factor I; Muscle Development; Myogenin; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Receptor, IGF Type 1; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sirolimus; TOR Serine-Threonine Kinases

2007